A Study of JNJ-87562761 in Participants With Relapsed or Refractory Multiple Myeloma - Clinical Trial NCTNCT06604715
Business Opportunities for NCT06604715
Connect with principal investigators, study coordinators, and key decision makers for this PHASE1 trial studying investigational therapy for Multiple Myeloma, Neoplasms, Plasma Cell.
Clinical Trial Information
- Study Sponsor
- Sponsor information available
- Drug/Intervention
- Study intervention details available
- Therapeutic Area
- Multiple Myeloma, Neoplasms, Plasma Cell
- Study Phase
- PHASE1
- Study Status
- RECRUITING
- NCT Number
- NCTNCT06604715
Find Contact Information
Access exclusive contact details for:
- Principal investigators and sub-investigators
- Study coordinators and research staff
- Site directors and facility contacts
- Sponsor representatives and CRO partners
- Business development professionals
- Clinical operations managers
Clinical Trial Locations
This study has 10 locations across Canada, Korea, Republic of, Spain.
Study Site
Toronto, Ontario Canada
Study Site
Seoul, Korea, Republic of
Study Site
Seoul, Korea, Republic of
Study Site
Seoul, Korea, Republic of
Study Site
Seoul, Korea, Republic of
Why Choose Quri.ai Study Finder
Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:
- Discover clinical trials before competitors
- Access exclusive contact information
- Track sponsor pipelines and opportunities
- Connect with decision makers directly
- Win more business partnerships